Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor

Published:2009-03 Issue:3 Volume:100 Page:552-557
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Maegawa Mari,Arao Tokuzo,Yokote Hideyuki,Matsumoto Kazuko,Kudo Kanae,Tanaka Kaoru,Kaneda Hiroyasu,Fujita Yoshihiko,Ito Fumiaki,Nishio Kazuto

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2008.01071.x/fullpdf

Reference34 articles.

1. Evidence for increased epidermal growth factor receptors in human sarcomas;Gusterson;Int J Cancer,1985

2. The neu oncogene encodes an epidermal growth factor receptor-related protein;Bargmann;Nature,1986

3. Increased EGF receptors on human squamous carcinoma cell lines;Cowley;Br J Cancer,1986

4. Epidermal growth factor receptor targeting in cancer;Mendelsohn;Semin Oncol,2006

5. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas;Karamouzis;JAMA,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors;Journal of Medical Genetics;2020-04-13

2. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients;Clinical Cancer Research;2018-03-05

3. Autophosphorylation of the carboxyl-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants;International Journal of Cancer;2018-03-05

4. Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?;Cancer Science;2016-07-14

5. Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non–Small Cell Lung Cancer: Double-Edged Sword of DDR2;Clinical Cancer Research;2016-01-29